A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Pet Iq, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 8,100 shares of PETQ stock, worth $250,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,100
Previous 86,500 90.64%
Holding current value
$250,938
Previous $1.91 Million 86.95%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$20.57 - $30.79 $1.61 Million - $2.41 Million
-78,400 Reduced 90.64%
8,100 $249,000
Q2 2024

Aug 14, 2024

SELL
$15.93 - $22.26 $1.04 Million - $1.45 Million
-65,200 Reduced 42.98%
86,500 $1.91 Million
Q1 2024

May 15, 2024

BUY
$15.55 - $19.42 $1.34 Million - $1.67 Million
86,200 Added 131.6%
151,700 $2.77 Million
Q4 2023

Feb 14, 2024

SELL
$17.18 - $22.38 $41,232 - $53,712
-2,400 Reduced 3.53%
65,500 $1.29 Million
Q3 2023

Nov 14, 2023

SELL
$15.0 - $20.71 $189,000 - $260,946
-12,600 Reduced 15.65%
67,900 $1.34 Million
Q2 2023

Aug 14, 2023

BUY
$10.84 - $15.43 $62,872 - $89,494
5,800 Added 7.76%
80,500 $1.22 Million
Q1 2023

May 15, 2023

BUY
$9.32 - $12.58 $524,716 - $708,254
56,300 Added 305.98%
74,700 $854,000
Q4 2022

Feb 14, 2023

SELL
$6.82 - $12.07 $229,152 - $405,552
-33,600 Reduced 64.62%
18,400 $169,000
Q3 2022

Nov 14, 2022

BUY
$6.9 - $18.16 $55,890 - $147,096
8,100 Added 18.45%
52,000 $359,000
Q2 2022

Aug 15, 2022

SELL
$14.09 - $25.12 $153,581 - $273,808
-10,900 Reduced 19.89%
43,900 $737,000
Q1 2022

May 16, 2022

BUY
$17.92 - $24.4 $982,016 - $1.34 Million
54,800 New
54,800 $1.34 Million
Q4 2017

Feb 14, 2018

SELL
$18.04 - $27.27 $198,440 - $299,970
-11,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$21.04 - $27.08 $231,440 - $297,880
11,000
11,000 $298,000

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.